Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review

BACKGROUND: Many studies reported high prevalence of antiphospholipid antibodies (aPL) in patients with COVID-19 raising questions about its true prevalence and its clinical impact on the disease course. METHODS: We conducted a meta-analysis and a systematic review to examine the prevalence of aPL a...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Muhanad, Samavati, Lobelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103564/
https://www.ncbi.nlm.nih.gov/pubmed/33958439
http://dx.doi.org/10.1136/rmdopen-2021-001580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103564/
https://www.ncbi.nlm.nih.gov/pubmed/33958439
http://dx.doi.org/10.1136/rmdopen-2021-001580

Ejemplares similares